Ethnicity and Renal Disease: Lessons From the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study

Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1990 • 4,310 citations

Multiple Risk Factor Intervention Trial

1982 • 1,670 citations

Systolic versus diastolic blood pressure and risk of coronary heart disease

1971 • 915 citations

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

1989 • 687 citations

Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of Diabetes

1989 • 519 citations

Roles of P2-purinoceptors in the cardiovascular system.

1991 • 471 citations

Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease.

1989 • 288 citations

Renal Function Change in Hypertensive Members of the Multiple Risk Factor Intervention Trial

1992 • 275 citations

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years

1984 • 267 citations

Renal Insufficiency in Treated Essential Hypertension

1989 • 254 citations

Progression of renal insufficiency: Role of blood pressure

1989 • 246 citations

An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status.

1983 • 231 citations

Race and Sex Differentials in the Impact of Hypertension in the United States

1989 • 210 citations

Does Racial Variation in Risk Factors Explain Black-White Differences in the Incidence of Hypertensive End-Stage Renal Disease?

1991 • 162 citations

Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence.

1989 • 145 citations

FAMILIAL AGGREGATION OF URINARY KALLIKREIN CONCENTRATION IN CHILDHOOD: RELATION TO BLOOD PRESSURE, RACE AND URINARY ELECTROLYTES1

1976 • 141 citations

Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT)

1977 • 141 citations

The Value of Aggressive Therapy in the Hypertensive Patient with Azotemia

1969 • 133 citations

The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function

1958 • 123 citations

Financial cost as an obstacle to hypertension therapy.

1986 • 122 citations

Chronic Low-Level Lead Exposure

1987 • 113 citations

The Association of Blood Pressure Levels and Change in Renal Function in Hypertensive and Nonhypertensive Subjects

1990 • 111 citations

Renal Vasculature in Essential Hypertension: Racial Differences

1978 • 103 citations

Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT)

1987 • 85 citations

Circadian variation of blood pressure in blacks: influence of age, gender and activity.

1990 • 83 citations

Cardiovascular and Renal Effects of Long-term Antihypertensive Treatment

1988 • 79 citations

Background and design of the new U.S. trial on diet and drug treatment of “mild” hypertension (TOMHS)

1987 • 78 citations

Cardiovascular Diseases in Blacks

1991 • 75 citations

Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.

1989 • 73 citations

Racial Disparity of Plasma Volume in Hypertensive Man

1976 • 70 citations

Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial

1984 • 70 citations

Renal Protective Effect of Strict Blood Pressure Control With Enalapril Therapy

1987 • 70 citations

Hypertension Management in the Multiple Risk Factor Intervention Trial (MRFIT)

1985 • 69 citations

Changing Patterns of End-Stage Renal Disease Due to Hypertension

1991 • 54 citations

Does a renal vasodilator system mediate racial differences in essential hypertension?

1980 • 48 citations

National High Blood Pressure Education Program Working Group Report on Hypertension and Chronic Renal Failure

1991 • 39 citations

Renin, aldosterone, sodium and hypertension

1972 • 34 citations

Effects of Propranolol Therapy on Renal Function and Body Fluid Composition

1983 • 34 citations

Cross-sectional differences in health status in US racial/ethnic minority groups: potential influence of temporal changes, disease, and life-style transitions.

1991 • 33 citations

Black-White Differences in Blood Pressure among Participants in NHANES II

1991 • 24 citations

Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS)

1990 • 19 citations

Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients

1990 • 13 citations

Minoxidil, Nadolol, and a Diuretic

1986 • 10 citations

Economic issues relating to access to medications.

1991 • 9 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...